WNT16 and cancer: Clinicopathological analyses of WNT16 mutant cancers revealed an association with MSI (mutant: 100% vs. Wt: 61.9%, p = 0.0054), right sided tumors (mutant: 100% vs. Wt: 86.8%, p = 0.038) and earlier stage at diagnosis (Mutant: 87.6% vs. Wt: 63.2%, p = 0.029).